English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Given that the patents of the first high cost and complex biopharmaceuticals have started to expire, biotechnology offers opportunities for developing countries to pursue an upgrading process by entering the sector as early imitators. In the case of biotechnology applied to the health sector, the characteristics of the innovation process and the specificity of the regulatory process for biopharmaceuticals raises new questions as to the learning path open to the developing countries that intend to build an industrial promotion strategy on the basis of early entry as imitators. Given those specific characteristics, it is worth asking how far creative imitation strategies could constitute an opportunity for late late industrializing countries to undertake rapid industrial upgrading processes.

Creative imitation in late industrializing countries: the case of biopharmaceutics in South Korea and India